SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment includes server-class CPUs, GPUs, AI accelerators, DPUs, FPGAs, SmartNICs, and Adaptive SoC products. The Client segment refers to the computing platforms, which are a collection of technologies that are designed to work together to provide a more complete computing solution. The Gaming segment is a fundamental component across many products and can be found in APU, GPU, SoC or a combination of a discrete GPU with another product working in tandem. The Embedded segment focuses on the embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending due to a significant deal with OpenAI, where AMD will become a core compute partner, potentially challenging NVIDIA's dominance in the AI chip market. The community is discussing the implications of OpenAI taking a stake in AMD and the potential for AMD to reach new price targets. This news is driving bullish sentiment and increased trading volume for AMD.

BTQ Technologies Corp. engages in the business of post-quantum encryption. It focuses on applications to the blockchain industry. Its products include PQScale, Keelug, Kenting, Preon, QPoW, and QByte. The company was founded by Nicolas Roussy Newton on March 26, 2021 and is headquartered in Vancouver, Canada.

BTQ Technologies Corp

BTQ Technologies is trending as it begins trading on the NASDAQ, generating excitement and volatility. The community is actively discussing its potential in post-quantum cryptography, comparing its valuation to sector peers, and speculating on future revenue and partnerships. Discussions include both bullish price targets and concerns about potential dilution following a recent shelf registration.

Spruce Biosciences, Inc. is a biopharmaceutical company, which engages in developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. The company was founded on November 13, 2014 and is headquartered in South San Francisco, CA.

Spruce Biosciences Inc

Spruce Biosciences Inc ($SPRB) is trending due to a significant surge following the FDA's Breakthrough Therapy Designation for its drug targeting Sanfilippo Syndrome Type B, a rare disease. The community is discussing the potential for continued upward momentum, with some comparing it to other high-flying stocks, while others caution about a potential pullback or offering. The stock's low float and the potential for a buyout are also being highlighted as contributing factors to the intense interest.

American Battery Technology Co. is a technology company, which engages in the development and marketing of lithium-ion batteries. Its projects include recycling plant, United States Advanced Battery Consortium (USABC), and Tonopah flats. The company was founded on October 6, 2011 and is headquartered in Reno, NV.

American Battery Technology Company

American Battery Technology Company ($ABAT) is trending as investors express bullish sentiment, anticipating a potential move towards $7 or $10. Community members highlight the stock's chart, recent volume, and the potential for significant gains, with some pointing to large call option purchases as a positive signal. Speculation around upcoming catalysts, such as the PFS, and potential government interest are also fueling discussions.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is trending due to reports of an SEC probe into its data collection practices, sparking debate about potential regulatory impacts. While some investors view the dip as a buying opportunity, citing strong fundamentals and analyst support, others express concern over the company's valuation and potential downside risks. The community is actively discussing the legitimacy and potential impact of the probe, with some dismissing it as a short-selling tactic.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PYPL is trending amid discussions about its potential for growth and valuation, with some traders pointing to its large user base and buyback program. Community members are debating whether the stock is undervalued or a bull trap, while also closely watching technical levels and potential catalysts. Recent news regarding partnerships and integrations may also be contributing to the increased interest.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending due to speculation around potential U.S. government investment in its Greenland rare earth project, with community members debating the validity and impact of conflicting reports. Discussions revolve around the company's non-dilutive funding, the Tanbreez project's economics, and potential for a short squeeze. Some traders are pointing to bullish technical indicators despite recent volatility.

Bitcoin SV (BSV) emerged following a hard fork of the Bitcoin Cash (BCH) blockchain in 2018, which had in turn forked from the BTC blockchain a year earlier. The goal of Bitcoin SV is to fulfil the original vision of the Bitcoin protocol and design as described in Satoshi Nakamoto’s white paper, early Bitcoin client software and known Satoshi writings. BSV aims to offer scalability and stability in line with the original description of Bitcoin as a peer-to-peer electronic cash system, as well as deliver a distributed data network that can support enterprise-level advanced blockchain applications. To this end, it has removed artificial block size limits and re-enabled Script commands and other technical capabilities which had been historically disabled or restricted by the protocol developers of the BTC blockchain. This allows the network to process tens of thousands of transactions per second while maintaining extremely low transaction fees for micropayments, in addition to offering advanced capabilities such as tokens, smart contracts, computation and other data use cases. The BSV network is unique in its capacity for unbounded on-chain scaling while also being more aligned with the original design of Bitcoin than any other blockchain.

Bitcoin SV

Bitcoin SV is trending as the community discusses its underlying technology, potential scalability with Teranode, and Craig Wright's ongoing trial, with some speculating about a market impact regardless of the outcome. Bullish community members highlight BSV's transaction capabilities and potential for real-world applications, while others remain skeptical, pointing to its controversial history and delisting from major exchanges. The discussion also includes comparisons to Bitcoin and other cryptocurrencies, focusing on BSV's unique technological approach and potential role in the broader crypto ecosystem.

Solid Power, Inc. engages in the manufacture and supply of power batteries. The firm develops all solid state battery cell technology that replaces the liquid or gel polymer electrolyte used in conventional lithium-ion battery cells with a sulfide-based solid electrolyte. It focuses on the development and commercialization of all solid state battery cells and solid electrolyte materials, primarily for the battery-powered electric vehicle market. The company was founded on August 3, 2011 and is headquartered in Louisville, CO.

Solid Power Inc

Solid Power Inc - Ordinary Shares - Class A

SLDP is trending due to positive sentiment surrounding solid-state battery technology and its potential applications, with community members highlighting partnerships, production milestones, and analyst ratings. Conversations suggest anticipation for news and potential short squeezes, with some speculating on the impact of solid-state batteries on electric vehicle performance. Discussions also include comparisons with competitors and varying views on market manipulation.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is trending due to its pivot towards AI infrastructure, with investors optimistic about its potential in the AI cloud services market. The community is discussing the company's contracted power and GPU deployments, while some debate its valuation compared to peers. Speculation around potential deals with major hyperscalers like OpenAI is fueling further interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SNY's Gene Therapy Candidate for Eye Disease Gets FDA Fast Track Tag

Sanofi's gene therapy SAR402663 for wet AMD earns FDA fast track status, aiming to speed up development and reduce treatment burden.

Are Options Traders Betting on a Big Move in Regenxbio Stock?

Investors need to pay close attention to RGNX stock based on the movements in the options market lately.

Regenxbio (RGNX) Reports Q2 Loss, Lags Revenue Estimates

Regenxbio (RGNX) delivered earnings and revenue surprises of -22.12% and -21.16%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Aligos Therapeutics, Inc. (ALGS) Reports Q2 Loss, Misses Revenue Estimates

Aligos Therapeutics (ALGS) delivered earnings and revenue surprises of +34.89% and -3.50%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Regenxbio (RGNX) Q1 Earnings and Revenues Lag Estimates

Biotech stocks jump as Makary outlines FDA vision, RBC comments

Investing.com -- Biotech stocks climbed Monday after new FDA Commissioner Dr. Marty Makary laid out a clear and collaborative regulatory strategy that analysts say bodes well for drug developers. In his first major interview since taking office, Makary emphasized pragmatic reforms, faster drug approvals, and modernized use of real-world data across the agency.

REGENXBIO to Participate in Upcoming Investor Conferences

REGENXBIO to Participate in Upcoming Investor Conferences REGENXBIO to Participate in Upcoming Investor Conferences PR Newswire ROCKVILLE, Md., Feb. 25, 2025 ROCKVILLE, Md., Feb. 25, 2025...

REGENXBIO Announces Presentations of RGX-121 at the 21st Annual WORLDSymposium 2025

REGENXBIO Announces Presentations of RGX-121 at the 21st Annual WORLDSymposium 2025 REGENXBIO Announces Presentations of RGX-121 at the 21st Annual WORLDSymposium 2025 PR Newswire ROCKVILLE, Md...

REGENXBIO and Nippon Shinyaku Announce Exclusive Partnership to Develop and Commercialize RGX-121 and RGX-111 for MPS Diseases

REGENXBIO and Nippon Shinyaku Announce Exclusive Partnership to Develop and Commercialize RGX-121 and RGX-111 for MPS Diseases REGENXBIO and Nippon Shinyaku Announce Exclusive Partnership to Develop...

AbbVie and REGENXBIO Announce Updates on the ABBV-RGX-314 Clinical Program

AbbVie and REGENXBIO Announce Updates on the ABBV-RGX-314 Clinical Program AbbVie and REGENXBIO Announce Updates on the ABBV-RGX-314 Clinical Program PR Newswire NORTH CHICAGO, Ill. and ROCKVILLE...

REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Regenxbio Inc

Will JP Morgan Chase ($JPM) beat quarterly earnings?  
 
*Powered by Polymarket

Stocktwits

JPMorgan Chase & Co

) beat quarterly earnings?  
 
*Powered by Polymarket

Current Price	$10.69
Prev Close	$10.43
Open	$10.53
Dividend Yield	0.00%
50-Day Moving Average	$9.03
Beta	1.51
Avg. Volume	487,646.38
PE Ratio	-3.09

52-Week High	$12.22
52-Week Low	$5.04
Market Capitalization	$540M
EPS (Annual)	-$4.59
Price to Book	2.52
Revenue Per Employee	$236,056.66
Enterprise Value/EBITDA	N/A

RGNX
Regenxbio Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest RGNX News

RGNX Regenxbio Inc